Is predicting metastatic phaeochromocytoma and paraganglioma still effective without methoxytyramine?

Emre Sedar Saygili1, Yasir S Elhassan2, Cristina L Ronchi2

  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale, Turkey; Institute of Metabolism and Systems Research, College of Medical and Dental Science, University of Birmingham, Birmingham B15 2TT, UK.

The Lancet. Digital Health
|February 23, 2024
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos